The Indian pharmaceutical sector has a long history of developing and delivering world-class products at affordable costs across the globe. As per IBEF data updated in June 2022, India has the greatest number of US FDA-approved units (741 as of August 2021). Indian pharma companies offer produ...
India announces expanded pharma growth at CPhIPharmexcil
India continues to maintain its leadership position in manufacturing and supply of high quality generic medicines. With several proactive measures by the Government, exports have improved and the growth in pharma sector is back on track, said Union Minister of Chemicals and Fertilizers D.V. Sadananda...
(FDA) until February 2009.48 India's generic houses are now entering into strategic alliances with global pharma companies to strengthen their generic portfolio and jointly market these drugs globally, The bottom line: 2008 saw M&A in the pharma sector in India more than double against the ...
India is set for record growth in 2023 after pharma manufacturers report surging international partnering at CPHI Frankfurt. Contract Manufacturing organisations (CMO) appear to be the biggest beneficiaries of new contracts, closely followed by API manufacturers in the country. In fact, for the first...
One of the critical factors that are expected to grow the market during the forecast period is accessibility, affordability, and the presence of a large number of retail stores offering OTC products. In developed and emerging countries, the increasing investment by the private sector to improve the...
For instance, in June 2021, Medly Pharmacy acquired Pharmaca, a pharmacy chain, to expand its presence across thirty different markets. The impact of regulations on the industry is significant. The FDA administers drug distribution and regulation, while state & local governments have some authority...
According to Taher Abbasi, COO & Co-Founder of Cellworks Research India, 2018 would witness an accelerating change for pharma & healthcare industry. The sector is set to take it to the next level and expected to see a huge adoption of artificial intelligence and big data in treatment process...
in capital expenditure for the pharma sector, actively working to establish an integrated CRDMO market supply system by upgrading research and manufacturing infrastructure, enhancing business development, and optimizing key business processes. The CRO facility in Hyderabad is nearing completion and will ...
Manufacturers of filler products have also experienced a positive impact with an increase in demand for minimally invasive aesthetic procedures. Several companies in the aesthetics sector are progressively introducing products to address the increasing demand for medical aesthetics. ...